Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phyllom BioProducts
AddedFeb 17, 2024
UpdatedJun 18, 2026
Phyllom BioProducts

Phyllom BioProducts

Series B

Phyllom BioProducts: A biotech firm providing eco-friendly solutions for invasive agricultural and turf insects.

HQ
Oakland, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees

Phyllom BioProducts is a plant biotechnology company focused on developing eco-friendly solutions for controlling invasive agricultural, forest, ornamental, livestock, and turf insects. Their products target pests like the Emerald Ash Borer, Goldspotted Oak Borer, Japanese Beetle, and Darkling Beetle, addressing unmet market needs with effective and environmentally responsible treatments.

Since its founding, Phyllom BioProducts has launched multiple products that have significantly impacted pest management practices. Their innovative use of proteins and platforms has garnered attention in the biotech industry, contributing to sustainable agriculture and forestry.

Phyllom BioProducts - Quick Facts

When was Phyllom BioProducts founded?

Phyllom BioProducts was founded in 2012.

Where is Phyllom BioProducts' headquarters located?

Phyllom BioProducts' headquarters is located in Oakland, CA, US.

When was Phyllom BioProducts' last funding round?

Phyllom BioProducts' most recent funding round was for $3M (USD) in February 2017.

How much has Phyllom BioProducts raised to-date?

As of Feb 15, 2017, Phyllom BioProducts has raised a total of $3.5M (USD).

How many employees does Phyllom BioProducts have?

Phyllom BioProducts has 30 employees as of Feb 5, 2024.

Phyllom BioProducts - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Insect Treatments
Tags
  • AgTech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services
  • 541600Management, Scientific, and Technical Consulting Services
  • 541610Management Consulting Services
  • 541613Marketing Consulting Services
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8740Management And Public Relations Services
  • 8742Management Consulting Services
Show 10 more industry codes
NAICS
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 7300Business Services
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research